JP2011015695A5 - - Google Patents

Download PDF

Info

Publication number
JP2011015695A5
JP2011015695A5 JP2010199379A JP2010199379A JP2011015695A5 JP 2011015695 A5 JP2011015695 A5 JP 2011015695A5 JP 2010199379 A JP2010199379 A JP 2010199379A JP 2010199379 A JP2010199379 A JP 2010199379A JP 2011015695 A5 JP2011015695 A5 JP 2011015695A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010199379A
Other versions
JP2011015695A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2011015695A publication Critical patent/JP2011015695A/ja
Publication of JP2011015695A5 publication Critical patent/JP2011015695A5/ja
Withdrawn legal-status Critical Current

Links

JP2010199379A 2004-10-27 2010-09-06 Nav1.8の短い干渉核酸阻害のための組成物および方法 Withdrawn JP2011015695A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62248404P 2004-10-27 2004-10-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007539118A Division JP2008517629A (ja) 2004-10-27 2005-10-26 Nav1.8の短い干渉核酸阻害のための組成物および方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013100220A Division JP2013176386A (ja) 2004-10-27 2013-05-10 Nav1.8の短い干渉核酸阻害のための組成物および方法

Publications (2)

Publication Number Publication Date
JP2011015695A JP2011015695A (ja) 2011-01-27
JP2011015695A5 true JP2011015695A5 (ja) 2011-06-16

Family

ID=36061603

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007539118A Withdrawn JP2008517629A (ja) 2004-10-27 2005-10-26 Nav1.8の短い干渉核酸阻害のための組成物および方法
JP2010199379A Withdrawn JP2011015695A (ja) 2004-10-27 2010-09-06 Nav1.8の短い干渉核酸阻害のための組成物および方法
JP2013100220A Pending JP2013176386A (ja) 2004-10-27 2013-05-10 Nav1.8の短い干渉核酸阻害のための組成物および方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007539118A Withdrawn JP2008517629A (ja) 2004-10-27 2005-10-26 Nav1.8の短い干渉核酸阻害のための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013100220A Pending JP2013176386A (ja) 2004-10-27 2013-05-10 Nav1.8の短い干渉核酸阻害のための組成物および方法

Country Status (14)

Country Link
US (4) US7786291B2 (ja)
EP (2) EP2371954A1 (ja)
JP (3) JP2008517629A (ja)
KR (1) KR20070083828A (ja)
CN (2) CN102352355A (ja)
AR (1) AR051829A1 (ja)
AU (1) AU2005299310A1 (ja)
CA (1) CA2584785A1 (ja)
IL (1) IL182680A0 (ja)
MX (1) MX2007005069A (ja)
NO (1) NO20072692L (ja)
SG (1) SG158921A1 (ja)
WO (1) WO2006047687A2 (ja)
ZA (1) ZA200703453B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1942948A4 (en) * 2005-11-04 2010-03-03 Alnylam Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF THE NAV1.8 GENE
US8183221B2 (en) 2007-09-05 2012-05-22 Medtronic, Inc. Suppression of SCN9A gene expression and/or function for the treatment of pain
MX2011000080A (es) 2008-06-30 2011-03-02 Janssen Pharmaceutica Nv Proceso para la preparacion de derivados de pirimidina sustituidos.
PE20141682A1 (es) * 2011-10-26 2014-11-14 Pfizer Ltd Derivados de (4-fenilimidazol-2-il) etilamina utiles como moduladores de canal de sodio
TWI516593B (zh) * 2012-06-11 2016-01-11 義守大學 一種聚核苷酸用以製備減緩疼痛藥物之用途
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
EP3294398A4 (en) * 2015-05-11 2019-01-09 Alcyone Lifesciences, Inc. SYSTEMS AND METHODS FOR DRUG DELIVERY
CA3045135A1 (en) 2016-12-21 2018-06-28 Alcyone Lifesciences, Inc. Drug delivery systems and methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513180D0 (en) 1995-06-28 1995-08-30 Univ London Ion channel
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AU2001245793A1 (en) * 2000-03-16 2001-09-24 Cold Spring Harbor Laboratory Methods and compositions for rna interference
DK1309726T4 (en) * 2000-03-30 2019-01-28 Whitehead Inst Biomedical Res RNA Sequence-Specific Mediators of RNA Interference
CZ308053B6 (cs) * 2000-12-01 2019-11-27 Max Planck Gesellschaft Izolovaná molekula dvouřetězcové RNA, způsob její výroby a její použití
GB0120238D0 (en) * 2001-08-20 2001-10-10 Univ College Of London Sodium channel regulators and modulators
EP1551424B1 (en) * 2002-09-04 2015-07-01 Arrowhead Research Corporation Treatment of chronic neuropathic pain by admistration of dsrna
WO2004087956A2 (en) * 2003-04-02 2004-10-14 Ionix Pharmaceuticals Limited Cell lines for the functional expression of nav1.8
WO2005014782A2 (en) * 2003-06-13 2005-02-17 Alnylam Europe Ag., Double-stranded ribonucleic acid with increased effectiveness in an organism
US7341835B2 (en) * 2004-01-13 2008-03-11 Affymetrix, Inc. Methods of analysis of alternative splicing in mouse

Similar Documents

Publication Publication Date Title
BR112013008959A2 (ja)
BR112012031500A2 (ja)
BR112012029986A2 (ja)
BR112012030039A2 (ja)
BR112012028408A2 (ja)
BR112012026492A2 (ja)
BR112012027808A2 (ja)
BR112012024897A2 (ja)
BR112012025307A2 (ja)
BR112012019354A2 (ja)
BR112012002126A2 (ja)
BR112012026946A2 (ja)
BR112012017960A2 (ja)
BR112012025482A2 (ja)
BR112013006400A2 (ja)
BR112012031826A2 (ja)
BR112012028186A2 (ja)
BR112012025577A2 (ja)
BR112012023249A2 (ja)
BR112012016456A2 (ja)
BR112012018256A2 (ja)
BR112012027015A2 (ja)
BR112012025308A2 (ja)
BR112012027945A2 (ja)
BR112012024872A2 (ja)